Novo Nordisk Estonia OÜ is the Estonian subsidiary of Novo Nordisk, a global pharmaceutical company specialising in diabetes care and other chronic disease treatments. Core business segments include research, sales and marketing of insulin, diabetes care devices, obesity care medications, and other biopharmaceutical products. Geographic scope includes Estonia, integrated with Novo Nordisk's Nordic and global operations. Strategic focus emphasizes patient-centric healthcare solutions, innovation in drug development, and expansion of local access to therapeutic treatments.
Headquarters
Paldiski mnt 29 Kristiine linnaosa
Tallinn; Harju county;
Postal Code: 10612
Contact Details: Purchase the Novo Nordisk Estonia OU report to view the information.
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service